Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins.
We have previously described a conserved set of peptides derived from lentiviral envelope transmembrane proteins that are similar to the natural antimicrobial peptides cecropins and magainins in overall structure but bear no sequence homology to them or other members of their class. We describe here an evaluation of the antimicrobial properties of these virally derived peptides, designated lentivirus lytic peptides (LLPs). The results of this study demonstrate that they are potent and selective antibacterial peptides: the prototype sequence, LLP1, is bactericidal to both gram-positive and gram-negative organisms at micromolar concentrations in 10 mM phosphate buffer. Furthermore, LLP1 kills bacteria quite rapidly, causing a 1,000-fold reduction in viable organisms within 50 s. Peptides corresponding to sequences from three lentivirus envelope proteins were synthesized and characterized. Several of these peptides are selective, killing bacteria at concentrations 50- to 100-fold lower than those required to lyse erythrocytes. Development of antimicrobial agents based on these peptides may lead to improved therapeutics for the management of a variety of infectious diseases.
Tencza
S B
SB
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
Douglass
J P
JP
Creighton
D J
DJ
Montelaro
R C
RC
Mietzner
T A
TA
D000900:Anti-Bacterial Agents / Q000302:isolation & purification* / Q000494:pharmacology*; D002478:Cells, Cultured; D015497:HIV-1; D006801:Humans; D004860:Infectious Anemia Virus, Equine; D008826:Microbial Sensitivity Tests; D010455:Peptides; D015302:Simian Immunodeficiency Virus; D014759:Viral Envelope Proteins / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D010455:Peptides; D014759:Viral Envelope Proteins